We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
19 hedge funds and large institutions have $64.9M invested in Enzymotec Ltd in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% more capital invested
Capital invested by funds: $57.1M → $64.9M (+$7.73M)
14% less funds holding
Funds holding: 22 → 19 (-3)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.19M |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
+$1.12M |
| 3 |
Millennium Management
New York
|
+$98.4K |
| 4 |
Morgan Stanley
New York
|
+$66.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$436 |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$1.82M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$392K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$319K |
| 4 |
PC
Paulson & Co
New York
|
-$239K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$221K |
